>
Date: Wed, 18 Feb 2004 08:36:53 -0800
X-Mailer: Microsoft Outlook IMO, Build 9.0.6604 (9.0.2911.0)
Third Annual BioE2E Alternative Funding Fair
SRI International, 333 Ravenswood Ave, Menlo Park, CA
Friday, February 27, 2004, Registration begins at 8:30AM, program
9:00 - 5:00
www.bioe2e.org/2004/fair
Join fellow entrepreneurs for a full day of valuable information
and insights directly from government agencies. Get the inside
story on what it really takes to get government funding and find
out about free resources that can help with your drug discovery
and development.
At BioE2E's third annual Alternative Funding Fair event, you will
learn about the various programs available, grant writing
strategies and tactics, determine if a grant is right for your
project, and meet government agency representatives.
Additionally, this year we have speakers addressing valuable
non-cash resources and drug development expertise available from
the National Cancer Institute.
This event will be of special interest to cancer researchers both
in academia and industry.
Besides presentations by grant awarding organizations, attendees
will have the opportunity to meet with law firms and other
service providers that provide assistance in grant management and
writing grant applications.
Previous year's highly successful events were each attended by
over 110 entrepreneurs. You must pre-register by Feb 23 to get
the discounted price.
Sponsored by SRI International, Synexis, DNA Bridges and Deloitte
& Touche
Invited speakers and topics include: (speakers subject to change)
* SBIR Grants & Contracts from the National Institutes of
Health -JoAnne Goodnight, NIH
* Funding Opportunities from the National Cancer Institute -
George Johnson, DTP, NCI
* Pharmastart - Glenn Rice, SRI
* The Rational Approach to Drug Development - Edward Sausville,
DTP, NCI
* Pathways to Drug Development Services at the NCI - Shannon
Decker, DTP
* Discovery and Molecular Targets - Susan Holbeck, DTP, NCI
* BioPharmaceutical Resources at the NCI - Stephen Creekmore,
DTP, NCI
* Late Stage Drug Development Issues - Dr. Joseph Tomaszewski,
DTP, NCI
* Technology Transfer and Intellectual Property Donna Bialozor,
TTB, NCI
* Grant Sources and Strategies - Cori Gorman, DNA Bridges
* Anatomy of a Grant Gail Schechter, BioIntelligence
* Post-Award Accounting - Hilarie Connolly, Deloitte & Touche
Also, breakout sessions with opportunities for advice on funding
strategy.
Registration Fee: $75 if pre-registered, $125 on the day (cash or
check only); this includes lunch and coffee breaks.
Pre-registration closes at 9am, Feb 23. Register online:
www.bioe2e.org/2004/fair
_______________________________________________
Startup mailing list
Startup_at_swiss-list.com
http://www.swiss-list.com/mailman/listinfo/startup
Received on Wed Feb 18 2004 - 17:58:11 PST
